Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Thibault

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Transplant Immunology|January 1, 2003
FasL-transfected endothelial cells decrease the proliferative response of allogeneic PBLSandrine Cappellesso, Gilles Thibault, Cyrille Hoarau, et al.
Pharmacogenetics and Genomics|December 11, 2013
Influence of FcγRIIIA genetic polymorphism on T-lymphocyte depletion induced by rabbit antithymocyte globulins in kidney transplant patientsDavid Ternant, Matthias Büchler, Gilles Thibault, et al.
British Journal of Clinical Pharmacology|August 28, 2019
CD4+ count-dependent concentration-effect relationship of rituximab in rheumatoid arthritisAmina Bensalem, Denis Mulleman, Gilles Thibault, et al.
Blood|March 4, 2006
Antibody-dependent cellular cytotoxicity (ADCC) is mediated by genetically modified antigen-specific human T lymphocytesBéatrice Clémenceau, Nicolas Congy-Jolivet, Géraldine Gallot, et al.
Arthritis Research & Therapy|October 30, 2016
Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatmentMatthieu Lavielle, Denis Mulleman, Philippe Goupille, et al.
Cancer Research|July 3, 2004
Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationshipSébastien Dall'Ozzo, Sophie Tartas, Gilles Paintaud, et al.
Blood|February 15, 2015
Increased risk of thrombosis in FcγRIIA 131RR patients with HIT due to defective control of platelet activation by plasma IgG2Jérôme Rollin, Claire Pouplard, Hsueh Cheng Sung, et al.
Clinical Pharmacokinetics|July 22, 2021
Relationship Between Antithymocyte Globulin Concentrations and Lymphocyte Sub-Populations in Kidney Transplant PatientsNicolas Azzopardi, Hélène Longuet, David Ternant, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 28, 2013
Risk factors for impaired CD4+ T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantationHélène Longuet, Bénédicte Sautenet, Philippe Gatault, et al.
Blood|March 29, 2019
Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopeniaClaire Kizlik-Masson, Quentin Deveuve, Yuhang Zhou, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Transplant Immunology|January 1, 2003
FasL-transfected endothelial cells decrease the proliferative response of allogeneic PBLSandrine Cappellesso, Gilles Thibault, Cyrille Hoarau, et al.
Pharmacogenetics and Genomics|December 11, 2013
Influence of FcγRIIIA genetic polymorphism on T-lymphocyte depletion induced by rabbit antithymocyte globulins in kidney transplant patientsDavid Ternant, Matthias Büchler, Gilles Thibault, et al.
British Journal of Clinical Pharmacology|August 28, 2019
CD4+ count-dependent concentration-effect relationship of rituximab in rheumatoid arthritisAmina Bensalem, Denis Mulleman, Gilles Thibault, et al.
Blood|March 4, 2006
Antibody-dependent cellular cytotoxicity (ADCC) is mediated by genetically modified antigen-specific human T lymphocytesBéatrice Clémenceau, Nicolas Congy-Jolivet, Géraldine Gallot, et al.
Arthritis Research & Therapy|October 30, 2016
Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatmentMatthieu Lavielle, Denis Mulleman, Philippe Goupille, et al.
Cancer Research|July 3, 2004
Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationshipSébastien Dall'Ozzo, Sophie Tartas, Gilles Paintaud, et al.
Blood|February 15, 2015
Increased risk of thrombosis in FcγRIIA 131RR patients with HIT due to defective control of platelet activation by plasma IgG2Jérôme Rollin, Claire Pouplard, Hsueh Cheng Sung, et al.
Clinical Pharmacokinetics|July 22, 2021
Relationship Between Antithymocyte Globulin Concentrations and Lymphocyte Sub-Populations in Kidney Transplant PatientsNicolas Azzopardi, Hélène Longuet, David Ternant, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 28, 2013
Risk factors for impaired CD4+ T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantationHélène Longuet, Bénédicte Sautenet, Philippe Gatault, et al.
Blood|March 29, 2019
Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopeniaClaire Kizlik-Masson, Quentin Deveuve, Yuhang Zhou, et al.
Pageof 4